Cidara Provides Corporate Update and Reports First Quarter 2019 Financial Results

NEXT STORY
BioCryst Completes Phase 1 Clinical Trial of Galidesivir
PREV STORY
CytomX Therapeutics Announces First Quarter 2019 Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

RedHill Biopharma Announces DDW 2018 Poster of Distinction on Positive Phase II Results with BEKINDA® for IBS-D

TEL-AVIV, Israel and RALEIGH, N.C., March 26, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. ...

author_avatar
NASDAQ Market News

Apricus Biosciences to Present at the 19th Annual BIO CEO & Investor Conference

SAN DIEGO, Feb. 08, 2017 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical ...

author_avatar
NASDAQ Market News

Celyad Announces Third Quarter 2017 Business Update

MONT-SAINT-GUIBERT, Belgium, Nov. 17, 2017 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD), a ...

author_avatar
NASDAQ Market News